Statement From ATPE State President Ginger Franks on CSCOPE debate
Date Posted: 8/22/2013 | Author: Jennifer Mitchell, CAE
Vice Chairman of the State Board of Education Thomas Ratliff and Senate Education Committee Chairman, and now candidate for Lieutenant Governor, Sen. Dan Patrick (R-Houston) will debate on education policy issues, including CSCOPE, on Saturday in Tyler, TX. The following is a statement regarding this debate from ATPE State President Ginger Franks, a special education teacher who represents the association’s 100,000-plus membership across the state. “This is not really about the merits of CSCOPE. It’s about the fact that a politician is trying to take away educators’ right to decide which lesson plans to use for purely political reasons. Tools like CSCOPE help teachers manage lesson plans and many districts, especially smaller school districts, rely heavily on this tool. It would be a shame to deny access to a tool that many teachers find helpful, especially when there isn’t a readily available replacement for it. This is a violation of educators’ right to teach the students in the way they feel is the most efficient and effective method, whether it is CSCOPE or not.” The debate will take place at 6:30 p.m. Saturday at the University of Texas -Tyler Ornelas Activity Center. ATPE encourages all educators to attend. For those that can't attend, the debate will be live streamed. The feed will be posted here on the TeachtheVote blog when it becomes available. Be sure to check back.
CONVERSATION
RECOMMENDED FOR YOU
05/01/2026
Teach the Vote’s Week in Review: May 1, 2026
Learn how the Department of Education’s proposed budget could impact Texas public education. Plus: ATPE’s Show Texas Teachers Love celebrates teachers throughout May.
05/01/2026
Secretary McMahon defends the Trump administration vision for dismantling the Department of Education
What does the FY 2027 Department of Education budget mean for Texas public schools?
05/01/2026
TRS Board of Trustees finalizes TRS-ActiveCare rates for 2026-27
TRS continues to outperform broader market trends, enabling reductions in some copays and coinsurance